[1] |
An Qinyan, Jiang Rong, Kang Bin, Du Ming, Zhou Renming, Zhao Hongjuan, Duan Yi, Lu Fei, Liu Jinming.
Levels and clinical significance of RDW, NT-proBNP, BigET-1, HMGB1 in patients with idiopathic pulmonary arterial hypertension
[J]. Clinical Focus, 2021, 36(11): 1001-1004.
|
[2] |
Quan Feng;Fan Xuemei;Fang Wenlong.
Clinical study of systemic lupus erythematosus associated pulmonary hypertension
[J]. Clinical Focus, 2015, 30(12): 1402-1.40414e+007.
|
[3] |
.
[J]. Clinical Focus, 2012, 27(3): 267-269.
|
[4] |
.
[J]. Clinical Focus, 2011, 26(15): 1371-1376.
|
[5] |
.
[J]. CLINICAL FOCUS, 2011, 26(14): 1278-1282.
|
[6] |
.
[J]. CLINICAL FOCUS, 2011, 26(9): 816-819.
|
[7] |
FU Song-quan;WANG Li;LIU Zhen-fen;LU Ting;WANG Li-hong.
Effect of phentolamine and diltiazem on pulmonary artery hypertension in exacerbations of chronic obstructive pulmonary disease patients with chronic cor pulmonale
[J]. CLINICAL FOCUS, 2011, 26(9): 772-774778.
|
[8] |
CHEN Yu-lin;LIU Min-jie.
Unilateral absence of a pulmonary artery:a case report and document analysis
[J]. CLINICAL FOCUS, 2011, 26(7): 584-590.
|
[9] |
.
[J]. CLINICAL FOCUS, 2009, 24(11): 974-976.
|
[10] |
HE Xiao-mei;ZHAO Li-na;FAN Wen-feng;LI Xiao-jing.
Study of operation indication in congenital ventricular septal defect with severe pulmonary hypertension by color Doppler echocardiography
[J]. CLINICAL FOCUS, 2008, 23(4): 241-243.
|
[11] |
.
[J]. CLINICAL FOCUS, 2007, 22(11): 798-799.
|
[12] |
.
[J]. CLINICAL FOCUS, 2006, 21(12): 895-897.
|